Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2009

Open Access 01-12-2009 | Research

PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells

Authors: Sara S Roscioni, Loes EM Kistemaker, Mark H Menzen, Carolina RS Elzinga, Reinoud Gosens, Andrew J Halayko, Herman Meurs, Martina Schmidt

Published in: Respiratory Research | Issue 1/2009

Login to get access

Abstract

Background

Airway smooth muscle contributes to the pathogenesis of pulmonary diseases by secreting inflammatory mediators such as interleukin-8 (IL-8). IL-8 production is in part regulated via activation of Gq-and Gs-coupled receptors. Here we study the role of the cyclic AMP (cAMP) effectors protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac1 and Epac2) in the bradykinin-induced IL-8 release from a human airway smooth muscle cell line and the underlying molecular mechanisms of this response.

Methods

IL-8 release was assessed via ELISA under basal condition and after stimulation with bradykinin alone or in combination with fenoterol, the Epac activators 8-pCPT-2'-O-Me-cAMP and Sp-8-pCPT-2'-O-Me-cAMPS, the PKA activator 6-Bnz-cAMP and the cGMP analog 8-pCPT-2'-O-Me-cGMP. Where indicated, cells were pre-incubated with the pharmacological inhibitors Clostridium difficile toxin B-1470 (GTPases), U0126 (extracellular signal-regulated kinases ERK1/2) and Rp-8-CPT-cAMPS (PKA). The specificity of the cyclic nucleotide analogs was confirmed by measuring phosphorylation of the PKA substrate vasodilator-stimulated phosphoprotein. GTP-loading of Rap1 and Rap2 was evaluated via pull-down technique. Expression of Rap1, Rap2, Epac1 and Epac2 was assessed via western blot. Downregulation of Epac protein expression was achieved by siRNA. Unpaired or paired two-tailed Student's t test was used.

Results

The β2-agonist fenoterol augmented release of IL-8 by bradykinin. The PKA activator 6-Bnz-cAMP and the Epac activator 8-pCPT-2'-O-Me-cAMP significantly increased bradykinin-induced IL-8 release. The hydrolysis-resistant Epac activator Sp-8-pCPT-2'-O-Me-cAMPS mimicked the effects of 8-pCPT-2'-O-Me-cAMP, whereas the negative control 8-pCPT-2'-O-Me-cGMP did not. Fenoterol, forskolin and 6-Bnz-cAMP induced VASP phosphorylation, which was diminished by the PKA inhibitor Rp-8-CPT-cAMPS. 6-Bnz-cAMP and 8-pCPT-2'-O-Me-cAMP induced GTP-loading of Rap1, but not of Rap2. Treatment of the cells with toxin B-1470 and U0126 significantly reduced bradykinin-induced IL-8 release alone or in combination with the activators of PKA and Epac. Interestingly, inhibition of PKA by Rp-8-CPT-cAMPS and silencing of Epac1 and Epac2 expression by specific siRNAs largely decreased activation of Rap1 and the augmentation of bradykinin-induced IL-8 release by both PKA and Epac.

Conclusion

Collectively, our data suggest that PKA, Epac1 and Epac2 act in concert to modulate inflammatory properties of airway smooth muscle via signaling to the Ras-like GTPase Rap1 and to ERK1/2.
Literature
1.
Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000, 161:1720–1745.CrossRefPubMed
2.
Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:S28-S38.CrossRefPubMed
3.
4.
Halayko AJ, Solway J: Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J Appl Physiol 2001, 90:358–368.PubMed
5.
Panettieri RA Jr: Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir Physiol Neurobiol 2003, 137:277–293.CrossRefPubMed
6.
Pang L, Knox AJ: Bradykinin stimulates IL-8 production in cultured human airway smooth muscle cells: role of cyclooxygenase products. J Immunol 1998, 161:2509–2515.PubMed
7.
Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol 1994, 55:97–179.CrossRefPubMed
8.
Kunkel SL, Standiford T, Kasahara K, Strieter RM: Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991, 17:17–23.CrossRefPubMed
9.
Shute J: Interleukin-8 is a potent eosinophil chemo-attractant. Clin Exp Allergy 1994, 24:203–206.CrossRefPubMed
10.
Richman-Eisenstat JB, Jorens PG, Hebert CA, Ueki I, Nadel JA: Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993, 264:L413-L418.PubMed
11.
Shute JK, Vrugt B, Lindley IJ, Holgate ST, Bron A, Aalbers R, Djukanovic R: Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997, 155:1877–1883.CrossRefPubMed
12.
Marini M, Vittori E, Hollemborg J, Mattoli S: Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992, 89:1001–1009.CrossRefPubMed
13.
Chanez P, Enander I, Jones I, Godard P, Bousquet J: Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int Arch Allergy Immunol 1996, 111:83–88.CrossRefPubMed
14.
Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M: Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002, 57:405–411.CrossRefPubMedPubMedCentral
15.
Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K, Narita N: Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997, 112:505–510.CrossRefPubMed
16.
Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA: Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J 2001, 17:1112–1119.CrossRefPubMed
17.
Fong CY, Pang L, Holland E, Knox AJ: TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE(2) release in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000, 279:L201-L207.PubMed
18.
Hayashi R, Yamashita N, Matsui S, Fujita T, Araya J, Sassa K, Arai N, Yoshida Y, Kashii T, Maruyama M, Sugiyama E, Kobayashi M: Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J 2000, 16:452–458.CrossRefPubMed
19.
Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL: Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 1992, 145:900–905.CrossRefPubMed
20.
Pyne NJ, Tolan D, Pyne S: Bradykinin stimulates cAMP synthesis via mitogen-activated protein kinase-dependent regulation of cytosolic phospholipase A2 and prostaglandin E2 release in airway smooth muscle. Biochem J 1997,328(Pt 2):689–694.CrossRefPubMedPubMedCentral
21.
Zhu YM, Bradbury DA, Pang L, Knox AJ: Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. J Biol Chem 2003, 278:29366–29375.CrossRefPubMed
22.
Huang CD, Tliba O, Panettieri RA Jr, Amrani Y: Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 2003, 28:330–338.CrossRefPubMed
23.
Kaur M, Holden NS, Wilson SM, Sukkar MB, Chung KF, Barnes PJ, Newton R, Giembycz MA: Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 2008, 295:L505-L514.CrossRefPubMed
24.
25.
Roscioni SS, Elzinga CR, Schmidt M: Epac: effectors and biological functions. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:345–357.CrossRefPubMed
26.
Rangarajan S, Enserink JM, Kuiperij HB, de RJ, Price LS, Schwede F, Bos JL: Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J Cell Biol 2003, 160:487–493.CrossRefPubMedPubMedCentral
27.
Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN: Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 2005, 105:1950–1955.CrossRefPubMed
28.
Kashima Y, Miki T, Shibasaki T, Ozaki N, Miyazaki M, Yano H, Seino S: Critical role of cAMP-GEFII--Rim2 complex in incretin-potentiated insulin secretion. J Biol Chem 2001, 276:46046–46053.CrossRefPubMed
29.
Fujimoto K, Shibasaki T, Yokoi N, Kashima Y, Matsumoto M, Sasaki T, Tajima N, Iwanaga T, Seino S: Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2.Piccolo complex in cAMP-dependent exocytosis. J Biol Chem 2002, 277:50497–50502.CrossRefPubMed
30.
Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, Scott JD: The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574–578.CrossRefPubMedPubMedCentral
31.
Fang Y, Olah ME: Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther 2007, 322:1189–1200.CrossRefPubMed
32.
Kiermayer S, Biondi RM, Imig J, Plotz G, Haupenthal J, Zeuzem S, Piiper A: Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. Mol Biol Cell 2005, 16:5639–5648.CrossRefPubMedPubMedCentral
33.
Wang Z, Dillon TJ, Pokala V, Mishra S, Labudda K, Hunter B, Stork PJ: Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol 2006, 26:2130–2145.CrossRefPubMedPubMedCentral
34.
Haag S, Warnken M, Juergens UR, Racke K: Role of Epac1 in mediating anti-proliferative effects of prostanoid EP(2) receptors and cAMP in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2008,378(6):617–30.CrossRefPubMed
35.
Huang SK, Wettlaufer SH, Chung J, Peters-Golden M: Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions Via Selective Actions of PKA and Epac-1. Am J Respir Cell Mol Biol 2008. 2008–0080OC
36.
Huston E, Lynch MJ, Mohamed A, Collins DM, Hill EV, MacLeod R, Krause E, Baillie GS, Houslay MD: EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation. Proc Natl Acad Sci USA 2008, 105:12791–12796.CrossRefPubMedPubMedCentral
37.
Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, Doskeland SO, Kristiansen K: Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol 2008, 28:3804–3816.CrossRefPubMedPubMedCentral
38.
Hochbaum D, Hong K, Barila G, Ribeiro-Neto F, Altschuler DL: Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis. J Biol Chem 2008, 283:4464–4468.CrossRefPubMed
39.
Kassel KM, Wyatt TA, Panettieri RA Jr, Toews ML: Inhibition of human airway smooth muscle cell proliferation by beta 2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement. Am J Physiol Lung Cell Mol Physiol 2008, 294:L131-L138.CrossRefPubMed
40.
Kooistra MRH, Corada M, Dejana E, Bos JL: Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Letters 2005, 579:4966–4972.CrossRefPubMed
41.
Gosens R, Stelmack GL, Dueck G, McNeill KD, Yamasaki A, Gerthoffer WT, Unruh H, Gounni AS, Zaagsma J, Halayko AJ: Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006, 291:L523-L534.CrossRefPubMed
42.
Gosens R, Dueck G, Gerthoffer WT, Unruh H, Zaagsma J, Meurs H, Halayko AJ: p42/p44 MAP kinase activation is localized to caveolae-free membrane domains in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1163-L1172.CrossRefPubMed
43.
Genth H, Huelsenbeck J, Hartmann B, Hofmann F, Just I, Gerhard R: Cellular stability of Rho-GTPases glucosylated by Clostridium difficile toxin B. FEBS Lett 2006, 580:3565–3569.CrossRefPubMed
44.
Nunes RO, Schmidt M, Dueck G, Baarsma H, Halayko AJ, Kerstjens HA, Meurs H, Gosens R: GSK-3/beta-catenin signaling axis in airway smooth muscle: role in mitogenic signaling. Am J Physiol Lung Cell Mol Physiol 2008, 294:L1110-L1118.CrossRefPubMed
45.
Schmidt M, Evellin S, Weernink PA, von DF, Rehmann H, Lomasney JW, Jakobs KH: A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat Cell Biol 2001, 3:1020–1024.CrossRefPubMed
46.
Holz GG, Chepurny OG, Schwede F: Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal 2008, 20:10–20.CrossRefPubMed
47.
Poppe H, Rybalkin SD, Rehmann H, Hinds TR, Tang XB, Christensen AE, Schwede F, Genieser HG, Bos JL, Doskeland SO, Beavo JA, Butt E: Cyclic nucleotide analogs as probes of signaling pathways. Nat Methods 2008, 5:277–278.CrossRefPubMed
48.
Laxman S, Riechers A, Sadilek M, Schwede F, Beavo JA: Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms. Proc Natl Acad Sci USA 2006, 103:19194–19199.CrossRefPubMedPubMedCentral
49.
Smolenski A, Bachmann C, Reinhard K, Hõnig-Liedl P, Jarchau T, Hoschuetzky H, Walter U: Analysis and regulation of vasodilator-stimulated phosphoprotein serin 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 1998, 273:20029–20035.CrossRefPubMed
50.
Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM: A family of cAMP-binding proteins that directly activate Rap1. Science 1998, 282:2275–2279.CrossRefPubMed
51.
Stork PJ, Schmitt JM: Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 2002, 12:258–266.CrossRefPubMed
52.
Schmidt M, Voss M, Thiel M, Bauer B, Grannass A, Tapp E, Cool RH, de GJ, von Eichel-Streiber C, Jakobs KH: Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases. J Biol Chem 1998, 273:7413–7422.CrossRefPubMed
53.
Enserink JM, Christensen AE, de RJ, van TM, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL: A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002, 4:901–906.CrossRefPubMed
54.
Obara Y, Labudda K, Dillon TJ, Stork PJ: PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 2004, 117:6085–6094.CrossRefPubMed
55.
Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998, 273:18623–18632.CrossRefPubMed
56.
57.
58.
Paegelow I, Werner H, Vietinghoff G, Wartner U: Release of cytokines from isolated lung strips by bradykinin. Inflamm Res 1995, 44:306–311.CrossRefPubMed
59.
Ammit AJ, Hoffman RK, Amrani Y, Lazaar AL, Hay DW, Torphy TJ, Penn RB, Panettieri RA Jr: Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 2000, 23:794–802.CrossRefPubMed
60.
Knox AJ, Corbett L, Stocks J, Holland E, Zhu YM, Pang L: Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB J 2001, 15:2480–2488.CrossRefPubMed
61.
62.
Stevens PA, Pyne S, Grady M, Pyne NJ: Bradykinin-dependent activation of adenylate cyclase activity and cyclic AMP accumulation in tracheal smooth muscle occurs via protein kinase C-dependent and -independent pathways. Biochem J 1994,297(Pt 1):233–239.CrossRefPubMedPubMedCentral
63.
Pyne NJ, Moughal N, Stevens PA, Tolan D, Pyne S: Protein kinase C-dependent cyclic AMP formation in airway smooth muscle: the role of type II adenylate cyclase and the blockade of extracellular-signal-regulated kinase-2 (ERK-2) activation. Biochem J 1994,304(Pt 2):611–616.CrossRefPubMedPubMedCentral
64.
de RJ, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL: Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474–477.CrossRef
65.
Schmitt JM, Stork PJ: PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1. Mol Cell 2002, 9:85–94.CrossRefPubMed
66.
McAvoy T, Zhou MM, Greengard P, Nairn AC: Phosphorylation of Rap1GAP, a striatally enriched protein, by protein kinase A controls Rap1 activity and dendritic spine morphology. Proc Natl Acad Sci USA 2009, 106:3531–3536.CrossRefPubMedPubMedCentral
67.
Mayr B, Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001, 2:599–609.CrossRefPubMed
68.
Borland G, Bird RJ, Palmer TM, Yarwood SJ: Activation of protein kinase C alpha by EPAC1 is required for the ERK- and C/EBPbeta-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells. J Biol Chem 2009,284(26):17391–403.CrossRefPubMedPubMedCentral
69.
Niimura M, Miki T, Shibasaki T, Fujimoto W, Iwanaga T, Seino S: Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J Cell Physiol 2009, 219:652–658.CrossRefPubMed
70.
Li Y, Asuri S, Rebhun JF, Castro AF, Paranavitana NC, Quilliam LA: The RAP1 guanine nucleotide exchange factor Epac2 couples cyclic AMP and Ras signals at the plasma membrane. J Biol Chem 2006, 281:2506–2514.CrossRefPubMed
71.
Wang Z, Dillon TJ, Pokala V, Mishra S, Labudda K, Hunter B, Stork PJ: Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol 2006, 26:2130–2145.CrossRefPubMedPubMedCentral
72.
Di Benedetto G, Zoccarato A, Lissandron V, Terrin A, Li X, Houslay MD, Baillie GS, Zaccolo M: Protein kinase A Type I and II define distinct intracellular signaling compartments. Circ Res 2008, 103:836–844.CrossRefPubMed
73.
Dodge-Kafka KLSJ, Pare GC, Michel JJC, Langeberg LK, Kapiloff MS, Scott JD: The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574–578.CrossRefPubMedPubMedCentral
74.
Nijholt IM, Dolga AM, Ostroveanu A, Luiten PGM, Schmidt M, Eisel ULM: Neuronal AKAP150 coordinates PKA and Epac mediated PKB/Akt phosphorylation. Cell Signal 2008, 20:1715–1724.CrossRefPubMed
Metadata
Title
PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells
Authors
Sara S Roscioni
Loes EM Kistemaker
Mark H Menzen
Carolina RS Elzinga
Reinoud Gosens
Andrew J Halayko
Herman Meurs
Martina Schmidt
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2009
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-10-88

Other articles of this Issue 1/2009

Respiratory Research 1/2009 Go to the issue

Research

Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study

Research

Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation

Research

Global gene expression patterns in the post-pneumonectomy lung of adult mice

Research

Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps

Review

Diet and asthma: looking back, moving forward

Research

Soy consumption and risk of COPD and respiratory symptoms: a case-control study in Japan
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits